News
8h
HealthDay on MSNFDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
11h
mlive on MSNEx-Red Wings center Mark Kirton dies at 67 after battle with ALS
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...
Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | Yet another biotech is facing a delay from the Food and Drug ...
Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...
Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.
Former Detroit Red Wings forward Mark Kirton, who enjoyed the most productive seasons of his NHL career with the franchise, has tragically lost his battle against ALS and passed away Sunday at just 67 ...
It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...
A patient with amyotrophic lateral sclerosis (ALS) has become the first person in the world to control an iPad entirely by ...
Certain subsets of microglia were found to be enriched in nervous system tissues from people with amyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results